2 weeks Ago
Vera Therapeutics ( NASDAQ: VERA ) priced an underwritten public offering of 7,142,858 shares at a price to the public of $42.00 per share. The gross proceeds are expected to be approximately $300M.
Underwriters have a 30-day option to purchase up to an additional ~1.07M shares. The offering is expected to close on October 31, 2024.
More on Vera Therapeutics Vera: Potential First Of Atacicept As A B-Cell Modulator For IgAN Patients Vera Therapeutics announces proposed public offering of class A common stock Vera stock closes 15% higher in wake of positive atacicept data.
